These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32073717)

  • 1. Targeting DNA binding proteins for cancer therapy.
    Shiroma Y; Takahashi RU; Yamamoto Y; Tahara H
    Cancer Sci; 2020 Apr; 111(4):1058-1064. PubMed ID: 32073717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current strategies and progress for targeting the "undruggable" transcription factors.
    Zhuang JJ; Liu Q; Wu DL; Tie L
    Acta Pharmacol Sin; 2022 Oct; 43(10):2474-2481. PubMed ID: 35132191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting transcription factors in multiple myeloma: evolving therapeutic strategies.
    Li S; Vallet S; Sacco A; Roccaro A; Lentzsch S; Podar K
    Expert Opin Investig Drugs; 2019 May; 28(5):445-462. PubMed ID: 30963799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting epigenetic regulators for cancer therapy.
    Wee S; Dhanak D; Li H; Armstrong SA; Copeland RA; Sims R; Baylin SB; Liu XS; Schweizer L
    Ann N Y Acad Sci; 2014 Feb; 1309():30-6. PubMed ID: 24571255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic mismatches with mutated transcribing genes at leukemogenic S-phase binding/start sites--potential targets for therapy with enzyme inhibitors.
    Prindull G
    Curr Stem Cell Res Ther; 2012 Nov; 7(6):420-9. PubMed ID: 23072459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A screening system to identify transcription factors that induce binding site-directed DNA demethylation.
    Suzuki T; Maeda S; Furuhata E; Shimizu Y; Nishimura H; Kishima M; Suzuki H
    Epigenetics Chromatin; 2017 Dec; 10(1):60. PubMed ID: 29221486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for Analysis of Transcription Factor DNA-Binding Specificity In Vitro.
    Jolma A; Taipale J
    Subcell Biochem; 2011; 52():155-73. PubMed ID: 21557082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Resolution Global Analysis of the Influences of Bas1 and Ino4 Transcription Factors on Meiotic DNA Break Distributions in Saccharomyces cerevisiae.
    Zhu X; Keeney S
    Genetics; 2015 Oct; 201(2):525-42. PubMed ID: 26245832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription factors and chromatin proteins as therapeutic targets in cancer.
    Johnston SJ; Carroll JS
    Biochim Biophys Acta; 2015 Apr; 1855(2):183-92. PubMed ID: 25721328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription factor based therapeutics: drugs of the future?
    Peterson MG; Baichwal VR
    Trends Biotechnol; 1993 Jan; 11(1):11-8. PubMed ID: 7763378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factor-DNA binding: beyond binding site motifs.
    Inukai S; Kock KH; Bulyk ML
    Curr Opin Genet Dev; 2017 Apr; 43():110-119. PubMed ID: 28359978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of transcription factor binding specificity models within and across cell lines.
    Sharmin M; Bravo HC; Hannenhalli S
    Genome Res; 2016 Aug; 26(8):1110-23. PubMed ID: 27311443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of transcription factors as agents and targets for drug development.
    Smith LM; Birrer MJ
    Oncology (Williston Park); 1996 Oct; 10(10):1532-8; discussion 1541-2. PubMed ID: 8905845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonconsensus Protein Binding to Repetitive DNA Sequence Elements Significantly Affects Eukaryotic Genomes.
    Afek A; Cohen H; Barber-Zucker S; Gordân R; Lukatsky DB
    PLoS Comput Biol; 2015 Aug; 11(8):e1004429. PubMed ID: 26285121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing transcription factor architectures for drug discovery.
    Blancafort P; Segal DJ; Barbas CF
    Mol Pharmacol; 2004 Dec; 66(6):1361-71. PubMed ID: 15340042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugging the 'undruggable'. Therapeutic targeting of protein-DNA interactions with the use of computer-aided drug discovery methods.
    Radaeva M; Ton AT; Hsing M; Ban F; Cherkasov A
    Drug Discov Today; 2021 Nov; 26(11):2660-2679. PubMed ID: 34332092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TFregulomeR reveals transcription factors' context-specific features and functions.
    Lin QXX; Thieffry D; Jha S; Benoukraf T
    Nucleic Acids Res; 2020 Jan; 48(2):e10. PubMed ID: 31754708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting heat shock transcription factor 1 for novel hyperthermia therapy (review).
    Tabuchi Y; Kondo T
    Int J Mol Med; 2013 Jul; 32(1):3-8. PubMed ID: 23636216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A conserved role for transcription factor sumoylation in binding-site selection.
    Rosonina E
    Curr Genet; 2019 Dec; 65(6):1307-1312. PubMed ID: 31093693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs for 'protein clouds': targeting intrinsically disordered transcription factors.
    Dunker AK; Uversky VN
    Curr Opin Pharmacol; 2010 Dec; 10(6):782-8. PubMed ID: 20889377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.